BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHI) — FDA Approval ANDA078794 (APOTEX)
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHI) — FDA Approval ANDA078794 (APOTEX) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE; Active ingredients: BENAZEPRIL HYDROCHLORIDE; HYDROCHLOR
| Brand name | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| Application number | ANDA078794 |
| Sponsor | APOTEX |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 20140821 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →